v3.25.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating activities    
Net loss $ (5,575,777) $ (12,542,693)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation, amortization and impairment 4,424 10,051
Equity-based compensation expense 273,730 524,838
Grant receivable writeoff 0 130,000
Changes in operating assets and liabilities:    
Grants receivable 0 1,480,490
Prepaid expenses and other current assets 492,471 807,770
Accounts payable 334,141 (2,255,477)
Accrued expenses and other current liabilities (54,326) (1,001,116)
Net cash (used in) operating activities (4,525,337) (12,846,137)
Financing activities    
Proceeds from issuance of equity securities 1,526,460 6,920,529
Payments on note payable (466,505) (280,917)
Net cash provided by financing activities 1,059,955 6,639,612
Net decrease in cash, cash equivalents and restricted cash (3,465,382) (6,206,525)
Cash, cash equivalents and restricted cash at beginning of period 5,899,910 12,106,435
Cash, cash equivalents and restricted cash at end of period 2,434,528 5,899,910
Supplemental disclosure of cash flow information:    
Cash paid for interest 10,643 14,754
Non-cash investing and financing activities:    
Insurance premium financed by note payable $ 398,728 $ 570,560